Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04193787 · ClinicalTrials.gov registry record · NA

EPIC-P Intervention

A NA study of HIV, sponsored by University of Connecticut.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT04193787 is a NA study of HIV that has completed, run by University of Connecticut. The registered enrollment target is 100 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04193787, a NA study of HIV, has completed, sponsored by University of Connecticut.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This non-randomized, open-label study will address the following research aims in People who inject drugs (PWID): * To assess the feasibility and acceptability of the Expanding PrEP Implementation in Communities of PWID (EPIC-P) intervention among high-risk PWID. * To determine the preliminary efficacy of the EPIC-P intervention in terms of increasing adherence to PrEP and primary HIV prevention among high-risk PWID.

Conditions Studied

Interventions

  • OTHER EPIC-P

Study Locations (1)

Connecticut

  • Storefront - New Haven

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2020-09-15
Est. Completion 2024-09-01
Phase NA

Sponsor

University of Connecticut

107 total trials

What the Registry Record Tells You About NCT04193787

The ClinicalTrials.gov registry entry for NCT04193787 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (77% lower). The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which EPIC-P is the first listed.

NCT04193787 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT04193787 about?

NCT04193787 is a clinical study titled "EPIC-P Intervention". This non-randomized, open-label study will address the following research aims in People who inject drugs (PWID): * To assess the feasibility and acceptability of the Expanding PrEP Implementation in Communities of PWID (EPIC-P) intervention among high-risk PWID. * To determine the preliminary effi...

What is the current status of trial NCT04193787?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2020-09-15. Estimated completion is 2024-09-01.

What conditions does trial NCT04193787 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT04193787?

The interventions under investigation include: EPIC-P (OTHER).

Who is sponsoring clinical trial NCT04193787?

This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04193787 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.